サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1634206

ヒステロスコープの世界市場 - 2025年～2033年

Global Hysteroscopes Market - 2025 - 2033

出版日
ページ情報
英文 176 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
ヒステロスコープの世界市場 - 2025年～2033年
出版日: 2025年01月13日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のヒステロスコープ市場は、2024年に2億6,040万米ドルに達し、2033年には4億2,400万米ドルに達すると予測され、予測期間2025年～2033年にはCAGR 5.6%で成長すると予測されています。

子宮鏡は、子宮（子宮）内部の視覚的検査に使用される医療器具です。特に婦人科処置用に設計された内視鏡の一種です。子宮頸管（子宮の下部）から子宮内に挿入できる細い管状の構造からなります。この装置には通常、光源とカメラが装備されており、医師はモニターで子宮内膜をリアルタイムで観察することができます。子宮鏡検査は通常、外来または病院で、手技の複雑さに応じて局所麻酔または全身麻酔下で行われます。子宮鏡は子宮頸管から子宮内に挿入され、炭酸ガスまたは生理食塩水を使用して子宮を拡張し、視認性を向上させることもあります。

子宮鏡市場は、婦人科疾患の有病率の増加や低侵襲処置のヒステロスコープの進歩の高まりなどの要因によって、大きな成長を遂げています。例えば、2024年5月、女性の健康医療機器の主要リーダーであるMeditrina社は、Gen 2バイポーラRF子宮鏡システムのFDA 510（k）認可を発表しました。この新システムはバイポーラ高周波技術を特徴とし、Aveta Gloと呼ばれる新しいバイポーラRF装置で、低侵襲の婦人科処置における重要な進歩を表しています。

市場力学：

促進要因と抑制要因

婦人科疾患の有病率の上昇

婦人科疾患の有病率の上昇は、ヒステロスコープ市場の成長を大きく後押ししており、予測期間中も市場を牽引するとみられます。子宮筋腫、子宮内膜ポリープ、異常子宮出血は、しばしば子宮鏡による評価や治療が必要となる一般的な婦人科疾患です。これらの疾患の世界の発生率は、年齢、ライフスタイルの変化、意識の高まりなどの要因によって上昇しています。

例えば、米国国立衛生研究所（NIH）によると、子宮平滑筋腫は女性における最も一般的な疾患の一つであるが、まだ研究が不十分です。一般に子宮筋腫として知られるこれらの腫瘍は、主に生殖期の女性に発症し、生涯のうちに白人女性の最大70％、アフリカ系女性の80％以上で診断されます。さらに、DynaMedによれば、子宮内膜ポリープは子宮出血異常のある閉経後患者の21％～28％、子宮出血異常のある閉経前患者の10％～40％で報告されています。

子宮内膜がん（子宮内膜のがん）は、特に閉経後の女性に多く見られるようになってきています。例えば、世界がん研究基金によると、2022年の子宮内膜がんの新規症例数は420,368例で、そのうち中国は77,722例、米国は66,055例、ロシアは29,852例、日本は18,338例、インドは17,240例です。子宮鏡検査は子宮内膜がんを発見するための重要な診断ツールであり、子宮内膜の生検や異常増殖の評価に使用することが不可欠であるため、高度な子宮鏡システムの需要が高まっています。

合併症のリスク

子宮鏡処置に伴う合併症のリスクは、子宮鏡市場の成長を妨げる重要な要因です。子宮鏡検査は一般に低侵襲で安全であると考えられているが、それでもなお、患者とヘルスケア提供者の双方がその処置を選ぶことを躊躇させるようなある種のリスクを伴う。

子宮鏡検査の最も深刻なリスクの一つは子宮穿孔で、子宮鏡が子宮壁に穴を開ける。まれではあるが、これは出血、感染、近傍臓器の損傷につながる可能性があり、早急な介入が必要となります。例えば、国立衛生研究所が発表した研究によると、子宮穿孔は子宮鏡手術の最も一般的な合併症の一つで、その発生率は0.8～1.5％です。子宮穿孔は、子宮頸管拡張中や子宮鏡挿入中に起こる可能性があります。このような合併症の恐怖は、患者が子宮鏡検査を選択する意欲を失わせ、特に経験の少ない医師がいる環境では、その導入が制限されることになります。

もう一つの重大な懸念は、処置中の感染の可能性であり、特に子宮内に異物が挿入された場合です。感染は骨盤内炎症性疾患（PID）や子宮内膜炎のような合併症を引き起こす可能性があり、抗生物質による治療が必要となります。感染のリスクは低いとはいえ、再入院や追加治療、回復期間の長期化につながる可能性があり、患者の満足度や手術全体の魅力に影響します。

過度の出血は、子宮鏡下手術、特に子宮筋腫核出術やポリープ切除術の際に起こりうるもう一つの合併症です。出血は多くの場合、電気手術器具の使用によりコントロールされるが、場合によってはさらなる外科的介入の必要性につながることもあります。

目次

第1章 市場イントロダクションと範囲

  • 報告書の目的
  • 調査範囲と定義
  • 調査範囲

第2章 エグゼクティブの洞察と重要なポイント

  • 市場のハイライトと戦略的ポイント
  • 主な動向と将来の予測
  • 製品タイプ別
  • 用途別
  • エンドユーザー別
  • 地域別

第3章 市場力学

  • 影響要因
    • 促進要因
      • 婦人科疾患の罹患率の上昇
    • 抑制要因
      • 合併症のリスク
    • 機会
    • 影響分析

第4章 戦略的洞察と業界展望

  • 市場のリーダーと先駆者
    • 新たな先駆者と著名な企業
    • 最大の売上を誇るブランドを確立したリーダー
    • 確立された製品を持つ市場リーダー
  • 新興スタートアップ企業と主要イノベーター
  • CXOの視点
  • 最新の開発とブレークスルー
  • ケーススタディ/進行中の調査
  • 規制と償還の情勢
    • 北米
    • 欧州
    • アジア太平洋地域
    • ラテンアメリカ
    • 中東・アフリカ
  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 特許分析
  • SWOT分析
  • アンメットニーズとギャップ
  • 市場参入と拡大のための推奨戦略
  • シナリオ分析ベストケース、ベースケース、ワーストケースの予測
  • 価格分析と価格市場力学

第5章 ヒステロスコープ市場、製品タイプ別

  • 硬性子宮鏡
  • フレキシブル子宮鏡
  • 使い捨て子宮鏡

第6章 ヒステロスコープ市場、用途別

  • 子宮筋腫摘出術
  • ポリープ切除術
  • 子宮内膜アブレーション
  • その他

第7章 ヒステロスコープ市場、エンドユーザー別

  • 病院
  • 婦人科クリニック
  • 外来手術センター
  • その他

第8章 ヒステロスコープ市場、地域別、市場分析と成長機会

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • スペイン
    • イタリア
    • その他欧州地域
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第9章 競合情勢と市場ポジショニング

  • 競合状況の概要と主要な市場企業
  • 市場シェア分析とポジショニングマトリックス
  • 戦略的パートナーシップ、合併、買収
  • 製品ポートフォリオとイノベーションにおける主な発展
  • 企業ベンチマーク

第10章 企業プロファイル

  • Olympus Corporation
    • 会社概要
    • 製品ポートフォリオと概要
    • 財務概要
    • 主な発展
    • SWOT分析
  • Stryker Corporation
  • Medtronic plc
  • Hologic, Inc.
  • KARL STORZ
  • Richard Wolf GmbH
  • Zhejiang Geyi Medical Instrument Co., Ltd
  • LiNA Medical ApS
  • Delmont imaging
  • Meditrina, Inc.

第11章 仮定と調査手法

  • データ収集方法
  • データの三角測量
  • 予測技術
  • データの検証と検証

第12章 付録

目次
Product Code: MD1458

The global hysteroscopes market reached US$ 260.4 million in 2024 and is expected to reach US$ 424.00 million by 2033, growing at a CAGR of 5.6% during the forecast period 2025-2033.

A hysteroscope is a medical instrument used for visual examination of the interior of the uterus (womb). It is a type of endoscope specifically designed for gynecological procedures. The device consists of a thin, tubular structure that can be inserted through the cervix (the lower part of the uterus) into the uterus. It is typically equipped with a light source and a camera, allowing the physician to view the uterine lining on a monitor in real time. Hysteroscopy is typically performed in an outpatient or hospital setting under local or general anesthesia, depending on the complexity of the procedure. The hysteroscope is inserted through the cervix into the uterus, and carbon dioxide or saline solution may be used to expand the uterus to improve visibility.

The hysteroscope market is experiencing significant growth, driven by factors such as the increasing prevalence of gynecological disorders and rising advancements in hysteroscopes for minimally invasive procedures. For instance, in May 2024, Meditrina, a key leader in women's health medical devices, announced the FDA 510(k) clearance of its Gen 2 bipolar RF hysteroscopy system. This new system features bipolar radiofrequency technology, and a new bipolar RF device called the Aveta Glo, representing a significant advancement in minimally invasive gynecologic procedures.

Market Dynamics: Drivers & Restraints

Rising prevalence of gynecology disorders

The rising prevalence of gynecology disorders is significantly driving the growth of the hysteroscopes market and is expected to drive the market over the forecast period. Uterine fibroids, endometrial polyps and abnormal uterine bleeding are common gynecological conditions that often necessitate hysteroscopic evaluation and treatment. The global incidence of these conditions is rising due to factors such as age, lifestyle changes, and increased awareness.

For instance, according to the National Institute of Health (NIH), Uterine leiomyomas are one of the most common and yet understudied diseases in women. These tumors, commonly known as fibroids, affect women mainly during their reproductive years and are diagnosed in up to 70% of white women and more than 80% of women of African ancestry during their lifetime. Additionally, according to DynaMed, endometrial polyps are reported in 21%-28% of postmenopausal patients with abnormal uterine bleeding and in 10%-40 % of premenopausal patients with abnormal uterine bleeding.

Endometrial cancer (cancer of the uterine lining) is becoming more common, especially in postmenopausal women. For instance, according to the World Cancer Research Fund, there were 420,368 new cases of endometrial cancer in 2022, including China with 77,722, the United States with 66,055, Russia with 29,852, Japan with 18,338 and India with 17,240. Hysteroscopy is a key diagnostic tool for detecting endometrial cancer, and its use in biopsies and assessments of the uterine lining for abnormal growths is essential, increasing the demand for advanced hysteroscopic systems.

Risk of complications

The risk of complications associated with hysteroscopic procedures is a significant factor hampering the growth of the hysteroscope market. While hysteroscopy is generally considered minimally invasive and safe, it still carries certain risks that can deter both patients and healthcare providers from opting for the procedure.

One of the most serious risks of hysteroscopy is uterine perforation, where the hysteroscope punctures the wall of the uterus. Although rare, this can lead to bleeding, infection, or injury to nearby organs, requiring immediate intervention. For instance, according to a study published by the National Institute of Health, uterine perforation is one of the most common complications of operative hysteroscopy with an incidence of 0.8-1.5%. Uterine perforation can happen during cervical dilation or during insertion of the hysteroscope. The fear of such complications can discourage patients from choosing hysteroscopy, limiting its adoption, especially in settings with less experienced practitioners.

Another significant concern is the potential for infection during the procedure, especially when foreign instruments are introduced into the uterus. Infections can lead to complications like pelvic inflammatory disease (PID) or endometritis, requiring antibiotic treatment. Though the risk of infection is low, it can still lead to hospital readmissions, additional treatments, and longer recovery times, which impacts patient satisfaction and the overall appeal of the procedure.

Excessive bleeding is another complication that can arise during hysteroscopic procedures, particularly in operative hysteroscopy (e.g., myomectomy or polypectomy). While bleeding is often controlled with the use of electrosurgical instruments, in some cases, it can lead to a need for further surgical intervention.

For more details on this report - Request for Sample

Segment Analysis

The global hysteroscopes market is segmented based on product type, application, end-user and region.

Product Type:

The disposable hysteroscope segment is expected to dominate the hysteroscopes market share

One of the primary advantages of disposable hysteroscopes is their single-use design, which eliminates the risk of cross-contamination and infection that can occur with reusable instruments. After each use, disposable hysteroscopes are discarded, ensuring that they are sterile for every procedure. The World Health Organization (WHO) has highlighted the importance of reducing infection risks in medical procedures, which has significantly influenced the adoption of single-use instruments like disposable hysteroscopes. Thus, many market players are focusing on disposable hysteroscopes.

For instance, in May 2024, Minerva Surgical announced the immediate and exclusive distribution of a new disposable hysteroscope that will be displayed at the Annual Clinical & Scientific Meeting of the American College of Obstetricians and Gynecologists in San Francisco, CA. The company plans to soon rebrand the new disposable hysteroscope as HERizon, and its goal is to redefine the standards of efficiency and accessibility in gynecological care.

While reusable hysteroscopes require significant upfront investment and maintenance costs (cleaning, sterilization, repairs), disposable hysteroscopes have a lower cost for healthcare facilities and eliminate the ongoing expenses associated with maintaining reusable equipment. This cost-effectiveness is particularly attractive to smaller healthcare providers and those in developing regions, where budget constraints are a concern.

Geographical Analysis

North America is expected to hold a significant position in the hysteroscopes market share

North America especially in the United States, is home to many leading and emerging manufacturers of hysteroscopes, such as Olympus Corporation, Karl Storz, UroViu Corp and Stryker Corporation, which continually push the envelope on technological innovations in the field. Innovations in high-definition cameras, flexible hysteroscopes, and single-use disposable models have contributed to the growth of the hysteroscope market in the region, as these advancements improve the accuracy, safety, and convenience of procedures.

For instance, in June 2022, UroViu Corp launched the new Hystero-V, a single-use hysteroscope compatible with UroViu's Always Ready endoscopy platform. The 12-Fr, semi-rigid, Hystero-V features a hydrophilic coating enabling gentle insertion and superior visualization for highly effective intrauterine examinations. The single-use hysteroscope eliminates the need for reprocessing the equipment, and the ease-of-use, portability, and time-saving aspects of the Hystero-V mean more efficient and comfortable procedures for both doctors and patients.

In North America, there is a high level of awareness around women's health, with strong healthcare campaigns focusing on early diagnosis and treatment of gynecological conditions. Institutions like the U.S. Department of Health and Human Services have launched programs targeting early detection of gynecological cancers, which drives the use of hysteroscopy for diagnosis and treatment. Public awareness campaigns, such as National Women's Health Week in the U.S., encourage women to undergo routine gynecological screenings, including hysteroscopy for conditions like abnormal uterine bleeding and fibroids.

Asia-Pacific is growing at the fastest pace in the hysteroscopes market

The Asia-Pacific region is witnessing an increase in the availability of advanced hysteroscopy technology, including high-definition cameras, flexible scopes, and disposable hysteroscopes. These innovations are enhancing the appeal of hysteroscopy in diagnosing and treating gynecological conditions with greater accuracy and minimal risk of infection. Countries like Japan and South Korea are leaders in adopting cutting-edge medical technologies, which are contributing to the growth of the hysteroscope market in the region.

In November 2022, India Medtronic Private Limited launched the TruClear system, a mechanical hysteroscopic tissue removal system used for the safe and effective treatment of intrauterine abnormalities (IUA). Some of the commonly seen IUA include fibroids, polyps, retained products of conception, adhesions, malignancies or hyperplasia.

Competitive Landscape

The major global players in the hysteroscopes market include Olympus Corporation, Stryker Corporation, Medtronic plc, Hologic, Inc., KARL STORZ, Richard Wolf GmbH, Zhejiang Geyi Medical Instrument Co., Ltd, LiNA Medical ApS, Delmont imaging, Meditrina, Inc. and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global hysteroscopes market report delivers a detailed analysis with 62 key tables, more than 54 visually impactful figures, and 167 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by Application
  • 2.5. Snippet by End-User
  • 2.6. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Prevalence of Gynecology Disorders
    • 3.1.2. Restraints
      • 3.1.2.1. Risk of Complications
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. Hysteroscopes Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Rigid Hysteroscope*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Flexible Hysteroscope
  • 5.4. Disposable Hysteroscope

6. Hysteroscopes Market, By Application

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 6.1.2. Market Attractiveness Index, By Application
  • 6.2. Myomectomy*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Polypectomy
  • 6.4. Endometrial Ablation
  • 6.5. Others

7. Hysteroscopes Market, By End-User

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.1.2. Market Attractiveness Index, By End-User
  • 7.2. Hospitals*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Gynecology Clinics
  • 7.4. Ambulatory Surgical Centers
  • 7.5. Others

8. Hysteroscopes Market, By Regional Market Analysis and Growth Opportunities

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 8.1.2. Market Attractiveness Index, By Region
  • 8.2. North America
    • 8.2.1. Introduction
    • 8.2.2. Key Region-Specific Dynamics
    • 8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.2.6.1. U.S.
      • 8.2.6.2. Canada
      • 8.2.6.3. Mexico
  • 8.3. Europe
    • 8.3.1. Introduction
    • 8.3.2. Key Region-Specific Dynamics
    • 8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.3.6.1. Germany
      • 8.3.6.2. U.K.
      • 8.3.6.3. France
      • 8.3.6.4. Spain
      • 8.3.6.5. Italy
      • 8.3.6.6. Rest of Europe
  • 8.4. South America
    • 8.4.1. Introduction
    • 8.4.2. Key Region-Specific Dynamics
    • 8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.4.6.1. Brazil
      • 8.4.6.2. Argentina
      • 8.4.6.3. Rest of South America
  • 8.5. Asia-Pacific
    • 8.5.1. Introduction
    • 8.5.2. Key Region-Specific Dynamics
    • 8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 8.5.6.1. China
      • 8.5.6.2. India
      • 8.5.6.3. Japan
      • 8.5.6.4. South Korea
      • 8.5.6.5. Rest of Asia-Pacific
  • 8.6. Middle East and Africa
    • 8.6.1. Introduction
    • 8.6.2. Key Region-Specific Dynamics
    • 8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

9. Competitive Landscape and Market Positioning

  • 9.1. Competitive Overview and Key Market Players
  • 9.2. Market Share Analysis and Positioning Matrix
  • 9.3. Strategic Partnerships, Mergers & Acquisitions
  • 9.4. Key Developments in Product Portfolios and Innovations
  • 9.5. Company Benchmarking

10. Company Profiles

  • 10.1. Olympus Corporation*
    • 10.1.1. Company Overview
    • 10.1.2. Product Portfolio and Description
    • 10.1.3. Financial Overview
    • 10.1.4. Key Developments
    • 10.1.5. SWOT Analysis
  • 10.2. Stryker Corporation
  • 10.3. Medtronic plc
  • 10.4. Hologic, Inc.
  • 10.5. KARL STORZ
  • 10.6. Richard Wolf GmbH
  • 10.7. Zhejiang Geyi Medical Instrument Co., Ltd
  • 10.8. LiNA Medical ApS
  • 10.9. Delmont imaging
  • 10.10. Meditrina, Inc.

LIST NOT EXHAUSTIVE

11. Assumption and Research Methodology

  • 11.1. Data Collection Methods
  • 11.2. Data Triangulation
  • 11.3. Forecasting Techniques
  • 11.4. Data Verification and Validation

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us